FDA Inspection 1280280 — Zhejiang Xianju Junye Pharmaceutical Co., Ltd.
The FDA completed an inspection of Zhejiang Xianju Junye Pharmaceutical Co., Ltd. on July 11, 2025 in Taizhou. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Veterinary.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 11, 2025
- Fiscal Year
- 2025
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Taizhou (China)